Record #46224
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
Publisher
Original paper date
Aug 18, 2022
Original DOI
Country
Institution
Department of Oncology, The Affiliated Shanghai No. 10 People's Hospital, Nanjing Medical University, Shanghai 200072, China · Department of Tumor Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou 215228, China · Fundamenta Therapeutice Co. Ltd, Suzhou 215200, China
Open access
No
Article type
Notes from Retraction Watch
See also: https://pubpeer.com/publications/5929CF426EB76480FC177DF8940711
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
1
Post-retraction
2
% post-retraction
66.7%
~0.0 citations/yr before retraction · ~0.6 citations/yr after
— citing papers
Who is still citing this work
Loading…